tiprankstipranks
Advertisement

CDC ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Buy
13Bullish
6Neutral
3Bearish
Oscillators
Buy
3Bullish
6Neutral
1Bearish
Moving Averages
Strong Buy
10Bullish
0Neutral
2Bearish
VictoryShares US EQ Income Enhanced Volatility Wtd ETF’s (CDC) Moving Averages Convergence Divergence (MACD) indicator is 0.80, suggesting VictoryShares US EQ Income Enhanced Volatility Wtd ETF is a Sell.
VictoryShares US EQ Income Enhanced Volatility Wtd ETF’s (CDC) 20-Day exponential moving average is 74.52, making it a Buy.
VictoryShares US EQ Income Enhanced Volatility Wtd ETF’s (CDC) 50-Day exponential moving average is 73.36, making it a Buy.

VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) Pivot Points

Jul 09, 2026, 12:58 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
75.43
75.84
76.12
76.53
76.81
77.22
77.50
Fibonacci
75.84
76.10
76.26
76.53
76.79
76.95
77.22

VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) Moving Averages

Jul 09, 2026, 12:58 AM
Period
Simple
Exponential
MA5
75.65Sell
75.59Sell
MA10
75.17Buy
75.18Buy
MA20
74.39Buy
74.52Buy
MA50
73.13Buy
73.36Buy
MA100
72.24Buy
71.96Buy
MA200
68.95Buy
69.21Buy
VictoryShares US EQ Income Enhanced Volatility Wtd ETF’s (CDC) 10-Day exponential moving average is 75.18, making it a Buy.
VictoryShares US EQ Income Enhanced Volatility Wtd ETF’s (CDC) 100-Day exponential moving average is 71.96, making it a Buy.
VictoryShares US EQ Income Enhanced Volatility Wtd ETF’s (CDC) 50-day simple moving average is 73.13, creating a Buy signal.
VictoryShares US EQ Income Enhanced Volatility Wtd ETF’s (CDC) 100-day simple moving average is 72.24, creating a Buy signal.
VictoryShares US EQ Income Enhanced Volatility Wtd ETF’s (CDC) 200-day simple moving average is 68.95, creating a Buy signal.

VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) Technical Analysis

Jul 09, 2026, 12:58 AM
Name
Value
Action
RSI (14)
59.14
Neutral
STOCH (9,6)
70.93
Neutral
STOCHRSI (14)
79.69
Neutral
MACD (12,26)
0.80
Sell
ADX (14)
23.48
Neutral
Williams %R
-35.21
Buy
CCI (14)
99.55
Neutral
ATR (14)
0.78
-
Ultimate Oscillator
49.51
Neutral
ROC
1.67
Buy
VictoryShares US EQ Income Enhanced Volatility Wtd ETF’s (CDC) Relative Strength Index (RSI) is 59.14, creating a Neutral signal.
VictoryShares US EQ Income Enhanced Volatility Wtd ETF’s (CDC) Trend Strength Indicator (ADX) is 23.48, creating a Neutral signal.
VictoryShares US EQ Income Enhanced Volatility Wtd ETF’s (CDC) Commodity Channel Index (CCI) is 99.55, creating a Neutral signal.
VictoryShares US EQ Income Enhanced Volatility Wtd ETF’s (CDC) Price Rate of Change (ROC) is 1.67, creating a Buy signal.

FAQ

Is CDC a Buy, Hold, or Sell?
Based on CDC’s technical indicators, CDC is a Buy.
    What is CDC’s RSI (14)?
    CDC’s RSI (14) is 59.14, which suggests CDC is a Neutral.
      What is CDC’s MACD?
      CDC’s MACD is 0.80, which suggests CDC is a Sell.
        What is CDC’s 5-day moving average?
        CDC’s 5-day moving average is 75.65, which suggests CDC is a Sell.
          What is CDC’s 20-day moving average?
          CDC 20-day moving average is 74.39, which suggests CDC is a Buy.
            What is CDC’s 50-day moving average?
            CDC’s 50-day moving average is 73.13, which suggests CDC is a Buy.
              What is CDC’s 200-day moving average?
              CDC’s 200-day moving average is 68.95, which suggests CDC is a Buy.
                What is CDC’s Williams % R (14)?
                CDC’s Williams % R (14) is -35.21, which suggests CDC is a Buy.
                  What is CDC’s CCI (14)?
                  CDC’s CCI (14) is 99.55, which suggests CDC is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis
                    Advertisement